Impact
The problem we're solving
Redefining emergency neurological care with smart, non-invasive bioelectronic therapies built for real-life patient needs.
Epilepsy represents a major global neurological challenge, affecting approximately 50 million people worldwide. Did you know that nearly 30% of epilepsy patients live with drug-resistant forms of the condition? This devastating reality severely impacts their quality of life and escalates the risk of life-threatening complications. In critical moments like status epilepticus or seizure clusters, every second counts making rapid, precise intervention vital to mitigate permanent neurological damage.
Real-World Impact
Technology Impact
By enabling ultra-rapid seizure intervention and optimized emergency response, our technology restores autonomy to patients and caregivers. Furthermore, it alleviates systemic healthcare pressure by reducing emergency admissions and making patient-centered neurological care globally accessible.
Clinical Impact
CLUSTREL seamlessly integrates advanced graphene technology, bioelectronics, and digital health into a scalable, clinically viable platform designed to redefine the future of neurological care.
Economic & Societal Impact
By minimising the need for emergency and ICU interventions, CLUSTREL significantly lowers healthcare expenditures, boosts societal productivity, and reduces the long-term socioeconomic burden of chronic disability.